Cargando…
Chronic heart failure treatment benefits from pro-BNP-directed therapy
Autor principal: | J, Aalbers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053649/ https://www.ncbi.nlm.nih.gov/pubmed/21298211 |
Ejemplares similares
-
NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008) -
Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007) -
The time-course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement
por: Prakaschandra, DR, et al.
Publicado: (2012) -
Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010) -
Serum high-sensitivity C-reactive protein, amyloid-associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia
por: Başkurt, M, et al.
Publicado: (2011)